Evidence for the presence of dipeptidyl carboxypeptidase and its inhibitors in inflammatory synovial fluids.
Evidence is reported for the presence of dipeptidyl carboxypeptidase (peptidyldipeptide hydrolase, EC 3.4.15.1) and of inhibitor(s) of this enzyme in synovial fluids from patients with rheumatoid arthritis and gout.
D001172:Arthritis, Rheumatoid / Q000201:enzymology*; D010450:Endopeptidases / Q000378:metabolism*; D006073:Gout / Q000201:enzymology*; D006801:Humans; D011480:Protease Inhibitors; D013582:Synovial Fluid / Q000201:enzymology*; D013722:Teprotide / Q000494:pharmacology
D011480:Protease Inhibitors; D013722:Teprotide; D010450:Endopeptidases; C020071:dipeptidyl carboxypeptidase